Heather Raymon

SVP, Research and Development · 2 filings · Latest: May 19, 2026

Artiva Biotherapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ARTV	Heather Raymon	SVP, Research and Development	May 19, 2026	Sale	$9.01	3,095	$27.9K	148,228	May 20 1:52 AM
ARTV	Heather Raymon	—	May 18, 2026	Proposed Sale	$9.22	3,500	$32.3K	—	May 18 11:54 PM